JP Morgan Chase
COYA icon

JP Morgan Chase’s Coya Therapeutics COYA Stock Holding History

JP Morgan Chase’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.9K Hold
5,000
– – ﹤0.01% 6565
2025
Q4 		$29K Hold
5,000
– – ﹤0.01% 6422
2025
Q3 		$28.5K Buy
+5,000
New +$30.4K ﹤0.01% 6393
2025
Q1 		– Sell
-32
Closed -$183 – 7370
2024
Q4 		$183 Buy
32
+1
+3% +$7 ﹤0.01% 6924
2024
Q3 		$200 Sell
31
-1
-3% -$6 ﹤0.01% 6905
2024
Q2 		$194 Sell
32
-498
-94% -$4K ﹤0.01% 6791
2024
Q1 		$5.26K Buy
530
+465
+715% +$3.64K ﹤0.01% 6443
2023
Q4 		$482 Buy
65
+60
+1,200% +$333 ﹤0.01% 6934
2023
Q3 		$19 Buy
+5
New +$20 ﹤0.01% 7173

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

JP Morgan Chase's COYA Position: Q1 2026 in Review

JP Morgan Chase held its Coya Therapeutics (COYA) position steady in Q1 2026 at 5,000 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6565.

JP Morgan Chase first reported a position in COYA in Q3 2023 and has held it in 9 quarters since. The position peaked at $29K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • JP Morgan Chase held 5,000 shares of Coya Therapeutics worth $18.9K as of Q1 2026.
  • JP Morgan Chase left its Coya Therapeutics share count unchanged in Q1 2026.
  • Coya Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6565 holding.
  • JP Morgan Chase first reported a position in Coya Therapeutics in Q3 2023 and has held it in 9 quarters since.
  • JP Morgan Chase's Coya Therapeutics position peaked at $29K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.